SEP
MEDP icon

Signature Equity Partners’s Medpace MEDP Stock Holding History

Signature Equity Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.12K Sell
4
-32
-89% -$14.8K ﹤0.01% 1167
2026
Q1 		$17.3K Sell
36
-132
-79% -$67.6K 0.01% 673
2025
Q4 		$94.4K Buy
+168
New +$95.4K 0.05% 280

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Signature Equity Partners's MEDP Position: Q2 2026 in Review

Signature Equity Partners reduced its Medpace (MEDP) stake by 89% in Q2 2026, selling an estimated $14.8K and leaving 4 shares worth $2.12K. The position accounts for ﹤0.01% of the portfolio, ranked #1167.

Signature Equity Partners first reported a position in MEDP in Q4 2025 and has held it in 3 quarters since. The position peaked at $94.4K in Q4 2025. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Signature Equity Partners held 4 shares of Medpace worth $2.12K as of Q2 2026.
  • Signature Equity Partners sold 32 Medpace shares in Q2 2026, an estimated $14.8K.
  • Medpace made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #1167 holding.
  • Signature Equity Partners first reported a position in Medpace in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Medpace position peaked at $94.4K in Q4 2025.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.